A tiny peptide found in a brain-tissue screen raised a big question: what helps a cell survive when it comes under stress? In 2001, Yuichi Hashimoto, Ikuo Nishimoto and colleagues at Keio University in Tokyo screened genetic material from a brain affected by Alzheimer's disease. They identified humanin, a peptide first described as a chain of twenty-four amino acids. Its sequence links it to mitochondrial DNA. A quarter century later, researchers are still following that clue. In the original experiments, humanin helped cultured nerve cells survive certain insults tied to Alzheimer's disease. A later team found one way it could work. When a cell is pushed toward programmed death, a protein called Bax can move to the outer mitochondrial membrane. In lab experiments, humanin bound Bax and interfered with that move, interrupting a step in the cell's death pathway. Then came an aging study. In 2020, worms engineered to make more humanin lived longer. In the same report, middle-aged mice given a modified version called H N G had less visceral fat and more lean mass, with no significant change in lifespan. The researchers also found higher circulating humanin in adult children of centenarians than in age-matched controls. That was a comparison of naturally occurring levels. It did not test whether giving humanin changes how people age. Humanin has no U.S. FDA approval. Its discovery still gives scientists a way to ask how mitochondria help decide whether a stressed cell survives. World Peptide Foundation. Peptides in 2. Every experience matters.